science

Tovorafenib

Tovorafenib is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Tovorafenib rather than just read about it. In short: Tovorafenib, sold under the brand name Ojemda, is a medication used for the treatment of glioma. It is a Type II RAF kinase inhibitor.

Key takeaways

Tovorafenib belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Tovorafenib to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Tovorafenib from memory before moving on to harder problems.

Reference excerpt

Tovorafenib, sold under the brand name Ojemda, is a medication used for the treatment of glioma. It is a Type II RAF kinase inhibitor. The most common adverse reactions include rash, hair color changes, fatigue, viral infection, vomiting, headache, hemorrhage, pyrexia, dry skin, constipation, nausea, dermatitis acneiform, and upper respiratory tract infection. The most common grade 3 or 4 laboratory abnormalities include decreased phosphate, decreased hemoglobin, increased creatinine phosphokinase, increased alanine aminotransferase, decreased albumin, decreased lymphocytes, decreased leukocytes, increased aspartate aminotransferase, decreased potassium, and decreased sodium. Tovorafenib was approved for medical use in the United States in April 2024, and is the first approval of a systemic therapy for the treatment of people with pediatric low-grade glioma with BRAF rearrangements, including fusions.

Medical uses Tovorafenib is indicated for the treatment of people six months of age and older with relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation.

History Tovorafenib was discovered in a collaboration among Sunesis Pharmaceuticals and Biogen Idec, which eventually expanded to include Millenium Pharmaceuticals, an affiliate of Takeda. In 2020, Day One Biopharmaceuticals, a company founded in 2018 to develop drugs for pediatric cancers, acquired Takeda's rights in the drug. Day One evaluated tovorafenib in 76 participants enrolled in FIREFLY-1 (NCT04775485), a multicenter, open-label, single-arm trial in participants with relapsed or refractory pediatric low-grade glioma harboring an activating BRAF alteration detected by a local laboratory who had received at least one line of prior systemic therapy. Participants were required to have documented evidence of radiographic progression and at least one measurable lesion. Participants with tumors harboring additional activating molecular alterations (e.g., IDH1/2 mutations, FGFR mutations) or with a known or suspected diagnosis of neurofibromatosis type 1 were excluded. Participants received tovorafenib based on body surface area (range: 290 to 476 mg/m2, up to a maximum dose of 600 mg) once weekly until they experienced disease progression or unacceptable toxicity. The US Food and Drug Administration (FDA) granted the application for tovorafenib priority review, breakthrough therapy, and orphan drug designations.

Society and culture

Legal status Tovorafenib was approved for medical use in the United States in April 2024.

Names Tovorafenib is the international nonproprietary name. Tovorafenib is sold under the brand name Ojemda.

References

External links "Tovorafenib". NCI Drug Dictionary. "Tovorafenib (Code C106254)". NCI Thesaurus. Clinical trial number NCT04775485 for "A Study to Evaluate DAY101 in Pediatric and Young Adult Patients With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors (FIREFLY-1)" at ClinicalTrials.gov

Worked examples

Example 1 — a first encounter with Tovorafenib

Start with the simplest possible case. Write down what Tovorafenib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Tovorafenib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Tovorafenib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Tovorafenib

In research: Tovorafenib appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Tovorafenib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Tovorafenib is common in secondary-school and first-year university syllabi. It links to neighbouring topics Brain tumor, Kinase inhibitors, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Tovorafenib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Tovorafenib” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Tovorafenib in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Tovorafenib means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Tovorafenib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Tovorafenib in simple terms?

Tovorafenib, sold under the brand name Ojemda, is a medication used for the treatment of glioma. It is a Type II RAF kinase inhibitor.

Why does Tovorafenib matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Tovorafenib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Tovorafenib.